Via Surgical Raises $6 Million for Cartidge-based Hernia Repair Device

Feirce Medical Devices reported that Israel’s Via Surgical brought in $6 million to develop its cartridge-based hernia repair device, a feather in the company’s cap more than a year after its product got an FDA green light.
According to the report:

Benslie Investment Group led the funding, giving Via Surgical a boost as it looks to expand its reach for its FasTouch Deployable Suture Fixation system. The device includes a reloadable cartridge with lockable sutures that close around the mesh and the tissue, which helps prevent foreign objects from getting in. FasTouch is also lightweight, the company said on its website, and having less material may cut down on adverse responses from the body or chronic pain in patients following a procedure.

Via Surgical CEO Lena Levin commented:

The addition of Benslie Investment Group to our highly experienced team validates the opportunity to advance patient care with the FasTouch Deployable Suture Fixation System. Their investment will greatly support the increasing clinical demand for improved fixation through our development and commercialization efforts in 2016.

Click here to view the full report.